Skip to main content
Fig. 5 | Molecular Medicine

Fig. 5

From: Targeting CLDN6 in germ cell tumors by an antibody-drug-conjugate and studying therapy resistance of yolk-sac tumors to identify and screen specific therapeutic options

Fig. 5

Graphical summary of the observed findings of this study. A Targetability of GCT cells by the CLDN6-ADC and provoked effects. B Molecular features of YST(-R) cells on DNA and protein level. C Molecular effects of the drugs screened as therapeutic option for YST(-R). Created using bioicons (https://bioicons.com/)

Back to article page